Contact Us
Hematopoietic Stem Cell Transplantation Global Market Report 2025
Global Hematopoietic Stem Cell Transplantation Market Report 2025

Report Price : $4490.00

Pages :

Format : PDF

Published : December 2025

Delivery Time : 2-3 Business Days

Purchase This Report Download Sample PDF
Purchase This Report

Hematopoietic Stem Cell Transplantation Global Market Report 2025

By Type (Allogeneic, Autologous), By Indication (Leukemia, Lymphatic Disorder, Myeloma, Other Non-Malignant Disorders), By Application (Bone Marrow Transplant, Peripheral Blood Stem Cell Transplant, Cord Blood Transplant), By End User (Hospital Pharmacy, Retail Pharmacy, Specialty Clinics) – Impact of Tariff and Trade War on Market Size, Growth, Trends, and Forecast 2025–2034

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Hematopoietic Stem Cell Transplantation Market Overview

• Hematopoietic Stem Cell Transplantation market size has reached to $4.68 billion in 2024

• Expected to grow to $7.7 billion in 2029 at a compound annual growth rate (CAGR) of 10.8%

• Growth Driver: Rising Blood Cancer Incidence Fuels Growth In The Hematopoietic Stem Cell Transplantation Market

• Market Trend: Product Approvals Drive Advancements In The Hematopoietic Stem Cell Transplantation Market

North America was the largest region in 2024.

What Is Covered Under Hematopoietic Stem Cell Transplantation Market?

Hematopoietic stem cell transplantation (HSCT) refers to the process of a medical procedure that is used to treat various blood and bone marrow disorders, such as certain genetic disorders and autoimmune diseases. The procedure involves replacing a patient's damaged or diseased bone marrow with healthy stem cells from a donor, which then grow and produce new blood cells in the patient's body. These stem cells can be obtained from bone marrow, peripheral blood, or umbilical cord blood.

The main types of cells in hematopoietic stem cell transplantation are Allogeneic and autologous. Allogeneic refers to a type of stem cell transplant in which the donor and recipient are different individuals with different genetic makeup. It was used to treat various indications such as leukemia, lymphatic disorders, myeloma, and others, and these are used for several applications, including bone marrow transplants, peripheral blood stem cell transplants, and cord blood transplants. The main end-users are hospital pharmacies, retail pharmacies, and specialty clinics.

Hematopoietic Stem Cell Transplantation Market Size and growth rate 2025 to 2029: Graph

What Is The Hematopoietic Stem Cell Transplantation Market Size 2025 And Growth Rate?

The hematopoietic stem cell transplantation market size has grown strongly in recent years. It will grow from$4.68 billion in 2024 to $5.1 billion in 2025 at a compound annual growth rate (CAGR) of 9.0%. The growth in the historic period can be attributed to early transplantation techniques, limited indications and donor sources, advancements in conditioning regimens, emergence of allogeneic transplants, regulatory milestones

What Is The Hematopoietic Stem Cell Transplantation Market Growth Forecast?

The hematopoietic stem cell transplantation market size is expected to see rapid growth in the next few years. It will grow to $7.7 billion in 2029 at a compound annual growth rate (CAGR) of 10.8%. The growth in the forecast period can be attributed to expanded treatment indications, donor source diversification, personalized medicine and genomics, regulatory changes and guidelines, market expansion and accessibility. Major trends in the forecast period include advancements in transplant techniques, expansion of indications, emerging cellular therapies, donor diversification, precision medicine approach.

The forecast of 10.8% growth over the next five years reflects a slight reduction of 0.1% from the previous projection. This reduction is primarily due to the impact of tariffs between the US and other countries. Trade tensions could hinder U.S. transplant programs by inflating prices of cell processing systems and cryopreservation media developed in Switzerland and Japan, resulting in delayed life-saving procedures and higher bone marrow transplant costs. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

Customer representative image Book your 30 minutes free consultation with our research experts

What’s The Trade War Impact On Healthcare Services Industry?

The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the healthcare sector, particularly in the supply of critical medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are facing higher costs for imported surgical instruments, imaging equipment, and consumables such as syringes and catheters, many of which have limited domestic alternatives. These increased costs are straining healthcare budgets, leading some providers to delay equipment upgrades or pass on expenses to patients. Additionally, tariffs on raw materials and components are disrupting the production of essential drugs and devices, causing supply chain bottlenecks. In response, the industry is diversifying sourcing strategies, boosting local manufacturing where possible, and advocating for tariff exemptions on life-saving medical products.

How Is The Hematopoietic Stem Cell Transplantation Market Segmented?

1) By Type: Allogeneic, Autologous

2) By Indication: Leukemia, Lymphatic Disorder, Myeloma, Other Non-Malignant Disorders

3) By Application: Bone Marrow Transplant, Peripheral Blood Stem Cell Transplant, Cord Blood Transplant

4) By End User: Hospital Pharmacy, Retail Pharmacy, Specialty Clinics

Subsegments:

1) By Allogeneic: Matched Related Donor Transplantation, Matched Unrelated Donor Transplantation, Cord Blood Transplantation

2) By Autologous: Peripheral Blood Stem Cell Transplantation, Bone Marrow Stem Cell Transplantation

What Is Driving The Hematopoietic Stem Cell Transplantation Market? Rising Blood Cancer Incidence Fuels Growth In The Hematopoietic Stem Cell Transplantation Market

The increased frequency of blood cancer is expected to propel the growth of the hematopoietic stem cell transplantation market. A group of malignancies that impact the development and operation of blood cells are referred to as blood cancers. Leukemia, lymphoma, and myeloma are the three main types of blood cancer. By replacing stem cells and bone marrow cells that have been killed by the malignancy, hematopoietic stem cell transplantation is generally used to treat blood cancer. These new stem cells can then move to the bone marrow and start creating new blood cells. So, these factors boost the hematopoietic stem cell transplantation market. For instance, in August 2022, according to the report shared by Blood Cancer UK, a UK-based non-profit organization, there are 41,000 blood cancer cases identified each year, making blood cancer the sixth most prevalent malignancy in the UK. Blood cancer, which affects one in 16 men and one in 22 women at some time in their lives, will afflict around 250,000 people in the UK in 2022. Additionally, more than 500 children under the age of 15 are affected by blood cancer each year. 400 of them have pediatric leukemia, and 100 of them have lymphoma. Therefore, the increased frequency of blood cancer drives the hematopoietic stem cell transplantation industry.

What Is Driving The Hematopoietic Stem Cell Transplantation Market? Rising Aging Population Drives Growth In The Hematopoietic Stem Cell Transplantation Market

The growing aging population is expected to propel the growth of the hematopoietic stem cell transplantation market. The ageing population refers to the elderly or older adults, who are typically defined as individuals aged 65 years and older. Hematopoietic stem cell transplantation (HSCT) is primarily used as a treatment for the aging population for various hematological disorders and in the presence of these disorders rather than as a direct anti-aging intervention and a more viable and promising option for older patients. For instance, in October 2022, according to the World Health Organization, a US-based specialized health agency, globally, 1 in 6 people will be 60 or older by 2030, and there will be a double number of individuals in this age group (2.1 billion) by 2050. Therefore, the growing aging population drives the hematopoietic stem cell transplantation industry.

Who Are The Major Players In The Global Hematopoietic Stem Cell Transplantation Market?

Major companies operating in the hematopoietic stem cell transplantation market include Pluristem Therapeutics Inc., Lonza Group AG, Escape Therapeutics Inc., Regen Biopharma Inc., Bluebird Bio Inc., CellGenix GmbH, CBR Systems Inc., Merck KGaA, Cord Blood Corporation, Kiadis Pharma NV, Marker Therapeutics Inc., Taiga Biotechnologies Inc., Takeda Pharmaceutical Company Limited, Talaris Therapeutics Inc., ViaCord LLC, ScienCell Research Laboratories Inc., BiolineRx, Stemcell Technologies Inc., ThermoGenesis Holdings Inc., MEDIPOST Co. Ltd., Anterogen. Co. Ltd., Pharmicell Inc., JCR Pharmaceuticals Co. Ltd., Holostem Terapie Avanzate Srl, Regrow Biosciences Pvt Ltd., Stempeutics Research Pvt Ltd.

What Are The Key Trends Of The Global Hematopoietic Stem Cell Transplantation Market? Product Approvals Drive Advancements In The Hematopoietic Stem Cell Transplantation Market

Product approvals are a key trend gaining popularity in the hematopoietic stem cell transplantation market. Major companies operating in the hematopoietic stem cell transplantation market are adopting product approvals to sustain their position in the market. For instance, in April 2022, Priothera Ltd., an Ireland-based late-clinical stage biotechnology company, received the United States Food and Drug Administration (FDA) clearance of an investigational new drug (IND) to begin an allogeneic hematopoietic stem cell transplant (HSCT) Phase IIb/III research study with mocravimod in patients with acute myeloid leukemia (AML). Mocravimod is a synthetic sphingosine 1-phosphate receptor (S1PR) modulator, also known as KRP203. Phase I and Phase II trials have evaluated the safety, tolerability, and effectiveness of this unique experimental medication for several autoimmune diseases.

What Are The Key Trends Of The Global Hematopoietic Stem Cell Transplantation Market? A Digital Resource For Hematopoietic Stem Cell Transplantation

Major companies operating in hematopoietic stem cell transplantation are focusing on developing innovations such as digital resources to streamline patient management, enhance donor matching processes, and provide real-time data analytics for better decision-making. Digital resources refer to various online tools, platforms, or materials that provide information, services, or functionalities in a digital format. For instance, in September 2024, BioLineRx Ltd., an Israel-based biopharmaceutical company, launched Mobilization Matters, a digital resource. Mobilization Matters is an interactive platform designed to educate healthcare professionals and patients about the mobilization of stem cells for transplantation. It offers comprehensive guidelines, best practices, and real-time tracking tools to optimize the stem cell collection process, thereby improving patient outcomes and ensuring efficient use of resources in transplantation procedures.

Need data on a specific region in this market?

Hematopoietic Stem Cell Transplantation Market Merger And Acquisition: Eurobio Scientific Group Expands Transplantation Portfolio With Acquisition Of Genome Diagnostics

In August 2022, Eurobio Scientific Group., a France-based biotechnology company, acquired Genome Diagnostics B.V., for $132.3 million. Through this acquisition, Eurobio Scientific Group. hopes to complete its commercial portfolio for evaluating the compatibility between donors and recipients regarding organ and marrow transplants. Genome Diagnostics B.V. is a Netherlands-based molecular diagnostics company that provides hematopoietic stem cell transplantation services.

Regional Analysis For The Global Hematopoietic Stem Cell Transplantation Market

North America was the largest region in the hematopoietic stem cell transplantation market in 2024. Asia-Pacific is expected to be the fastest-growing region in the global hematopoietic stem cell transplantation market during the forecast period. The regions covered in this market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

What Defines the Hematopoietic Stem Cell Transplantation Market?

The hematopoietic stem cell transplantation (HSCT) market includes revenues earned by entities providing services such as medical evaluation, pre-transplant care, stem cell collection and processing, transplantation procedures, post-transplant care, supportive care, and long-term follow-up. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What is the Market Assessment and Strategic Outlook for the Hematopoietic Stem Cell Transplantation Industry?

The hematopoietic stem cell transplantation market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the hematopoietic stem cell transplantation industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Hematopoietic Stem Cell Transplantation Market Report Forecast Analysis

Report AttributeDetails
Market Size Value In 2025 $5.1 billion
Revenue Forecast In 2034 $7.7 billion
Growth Rate CAGR of 10.8% from 2025 to 2034
Base Year For Estimation 2024
Actual Estimates/Historical Data 2019-2024
Forecast Period 2025 - 2029 - 2034
Market Representation Revenue in USD Billion and CAGR from 2025 to 2034
Segments Covered 1) By Type: Allogeneic, Autologous
2) By Indication: Leukemia, Lymphatic Disorder, Myeloma, Other Non-Malignant Disorders
3) By Application: Bone Marrow Transplant, Peripheral Blood Stem Cell Transplant, Cord Blood Transplant
4) By End User: Hospital Pharmacy, Retail Pharmacy, Specialty Clinics Subsegments: 1) By Allogeneic: Matched Related Donor Transplantation, Matched Unrelated Donor Transplantation, Cord Blood Transplantation
2) By Autologous: Peripheral Blood Stem Cell Transplantation, Bone Marrow Stem Cell Transplantation
Regional Scope Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain. Additional countries that can be covered in the report are Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, Mexico, Chile, Argentina, Colombia, Peru, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Key Companies Profiled Pluristem Therapeutics Inc., Lonza Group AG, Escape Therapeutics Inc., Regen Biopharma Inc., Bluebird Bio Inc., CellGenix GmbH, CBR Systems Inc., Merck KGaA, Cord Blood Corporation, Kiadis Pharma NV, Marker Therapeutics Inc., Taiga Biotechnologies Inc., Takeda Pharmaceutical Company Limited, Talaris Therapeutics Inc., ViaCord LLC, ScienCell Research Laboratories Inc., BiolineRx, Stemcell Technologies Inc., ThermoGenesis Holdings Inc., MEDIPOST Co. Ltd., Anterogen. Co. Ltd., Pharmicell Inc., JCR Pharmaceuticals Co. Ltd., Holostem Terapie Avanzate Srl, Regrow Biosciences Pvt Ltd., Stempeutics Research Pvt Ltd.
Customization ScopeRequest for Sample
Pricing And Purchase OptionsExplore Purchase Options

Table Of Contents

1. Executive Summary

2. Hematopoietic Stem Cell Transplantation Market Characteristics

3. Hematopoietic Stem Cell Transplantation Market Trends And Strategies

4. Hematopoietic Stem Cell Transplantation Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Hematopoietic Stem Cell Transplantation Growth Analysis And Strategic Analysis Framework

5.1. Global Hematopoietic Stem Cell Transplantation PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

5.2. Analysis Of End Use Industries

5.3. Global Hematopoietic Stem Cell Transplantation Market Growth Rate Analysis

5.4. Global Hematopoietic Stem Cell Transplantation Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)

5.5. Global Hematopoietic Stem Cell Transplantation Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)

5.6. Global Hematopoietic Stem Cell Transplantation Total Addressable Market (TAM)

6. Hematopoietic Stem Cell Transplantation Market Segmentation

6.1. Global Hematopoietic Stem Cell Transplantation Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Allogeneic

Autologous

6.2. Global Hematopoietic Stem Cell Transplantation Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Leukemia

Lymphatic Disorder

Myeloma

Other Non-Malignant Disorders

6.3. Global Hematopoietic Stem Cell Transplantation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Bone Marrow Transplant

Peripheral Blood Stem Cell Transplant

Cord Blood Transplant

6.4. Global Hematopoietic Stem Cell Transplantation Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Hospital Pharmacy

Retail Pharmacy

Specialty Clinics

6.5. Global Hematopoietic Stem Cell Transplantation Market, Sub-Segmentation Of Allogeneic, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Matched Related Donor Transplantation

Matched Unrelated Donor Transplantation

Cord Blood Transplantation

6.6. Global Hematopoietic Stem Cell Transplantation Market, Sub-Segmentation Of Autologous, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Peripheral Blood Stem Cell Transplantation

Bone Marrow Stem Cell Transplantation

7. Hematopoietic Stem Cell Transplantation Market Regional And Country Analysis

7.1. Global Hematopoietic Stem Cell Transplantation Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

7.2. Global Hematopoietic Stem Cell Transplantation Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Hematopoietic Stem Cell Transplantation Market

8.1. Asia-Pacific Hematopoietic Stem Cell Transplantation Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

8.2. Asia-Pacific Hematopoietic Stem Cell Transplantation Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.3. Asia-Pacific Hematopoietic Stem Cell Transplantation Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.4. Asia-Pacific Hematopoietic Stem Cell Transplantation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Hematopoietic Stem Cell Transplantation Market

9.1. China Hematopoietic Stem Cell Transplantation Market Overview

9.2. China Hematopoietic Stem Cell Transplantation Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.3. China Hematopoietic Stem Cell Transplantation Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.4. China Hematopoietic Stem Cell Transplantation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Hematopoietic Stem Cell Transplantation Market

10.1. India Hematopoietic Stem Cell Transplantation Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.2. India Hematopoietic Stem Cell Transplantation Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.3. India Hematopoietic Stem Cell Transplantation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Hematopoietic Stem Cell Transplantation Market

11.1. Japan Hematopoietic Stem Cell Transplantation Market Overview

11.2. Japan Hematopoietic Stem Cell Transplantation Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.3. Japan Hematopoietic Stem Cell Transplantation Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.4. Japan Hematopoietic Stem Cell Transplantation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Hematopoietic Stem Cell Transplantation Market

12.1. Australia Hematopoietic Stem Cell Transplantation Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.2. Australia Hematopoietic Stem Cell Transplantation Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.3. Australia Hematopoietic Stem Cell Transplantation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Hematopoietic Stem Cell Transplantation Market

13.1. Indonesia Hematopoietic Stem Cell Transplantation Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.2. Indonesia Hematopoietic Stem Cell Transplantation Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.3. Indonesia Hematopoietic Stem Cell Transplantation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Hematopoietic Stem Cell Transplantation Market

14.1. South Korea Hematopoietic Stem Cell Transplantation Market Overview

14.2. South Korea Hematopoietic Stem Cell Transplantation Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.3. South Korea Hematopoietic Stem Cell Transplantation Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.4. South Korea Hematopoietic Stem Cell Transplantation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Hematopoietic Stem Cell Transplantation Market

15.1. Western Europe Hematopoietic Stem Cell Transplantation Market Overview

15.2. Western Europe Hematopoietic Stem Cell Transplantation Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.3. Western Europe Hematopoietic Stem Cell Transplantation Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.4. Western Europe Hematopoietic Stem Cell Transplantation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Hematopoietic Stem Cell Transplantation Market

16.1. UK Hematopoietic Stem Cell Transplantation Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.2. UK Hematopoietic Stem Cell Transplantation Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.3. UK Hematopoietic Stem Cell Transplantation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Hematopoietic Stem Cell Transplantation Market

17.1. Germany Hematopoietic Stem Cell Transplantation Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.2. Germany Hematopoietic Stem Cell Transplantation Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.3. Germany Hematopoietic Stem Cell Transplantation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Hematopoietic Stem Cell Transplantation Market

18.1. France Hematopoietic Stem Cell Transplantation Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.2. France Hematopoietic Stem Cell Transplantation Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.3. France Hematopoietic Stem Cell Transplantation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Hematopoietic Stem Cell Transplantation Market

19.1. Italy Hematopoietic Stem Cell Transplantation Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.2. Italy Hematopoietic Stem Cell Transplantation Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.3. Italy Hematopoietic Stem Cell Transplantation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Hematopoietic Stem Cell Transplantation Market

20.1. Spain Hematopoietic Stem Cell Transplantation Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.2. Spain Hematopoietic Stem Cell Transplantation Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.3. Spain Hematopoietic Stem Cell Transplantation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Hematopoietic Stem Cell Transplantation Market

21.1. Eastern Europe Hematopoietic Stem Cell Transplantation Market Overview

21.2. Eastern Europe Hematopoietic Stem Cell Transplantation Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.3. Eastern Europe Hematopoietic Stem Cell Transplantation Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.4. Eastern Europe Hematopoietic Stem Cell Transplantation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Hematopoietic Stem Cell Transplantation Market

22.1. Russia Hematopoietic Stem Cell Transplantation Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.2. Russia Hematopoietic Stem Cell Transplantation Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.3. Russia Hematopoietic Stem Cell Transplantation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Hematopoietic Stem Cell Transplantation Market

23.1. North America Hematopoietic Stem Cell Transplantation Market Overview

23.2. North America Hematopoietic Stem Cell Transplantation Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.3. North America Hematopoietic Stem Cell Transplantation Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.4. North America Hematopoietic Stem Cell Transplantation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Hematopoietic Stem Cell Transplantation Market

24.1. USA Hematopoietic Stem Cell Transplantation Market Overview

24.2. USA Hematopoietic Stem Cell Transplantation Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.3. USA Hematopoietic Stem Cell Transplantation Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.4. USA Hematopoietic Stem Cell Transplantation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Hematopoietic Stem Cell Transplantation Market

25.1. Canada Hematopoietic Stem Cell Transplantation Market Overview

25.2. Canada Hematopoietic Stem Cell Transplantation Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.3. Canada Hematopoietic Stem Cell Transplantation Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.4. Canada Hematopoietic Stem Cell Transplantation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Hematopoietic Stem Cell Transplantation Market

26.1. South America Hematopoietic Stem Cell Transplantation Market Overview

26.2. South America Hematopoietic Stem Cell Transplantation Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.3. South America Hematopoietic Stem Cell Transplantation Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.4. South America Hematopoietic Stem Cell Transplantation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Hematopoietic Stem Cell Transplantation Market

27.1. Brazil Hematopoietic Stem Cell Transplantation Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.2. Brazil Hematopoietic Stem Cell Transplantation Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.3. Brazil Hematopoietic Stem Cell Transplantation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Hematopoietic Stem Cell Transplantation Market

28.1. Middle East Hematopoietic Stem Cell Transplantation Market Overview

28.2. Middle East Hematopoietic Stem Cell Transplantation Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.3. Middle East Hematopoietic Stem Cell Transplantation Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.4. Middle East Hematopoietic Stem Cell Transplantation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Hematopoietic Stem Cell Transplantation Market

29.1. Africa Hematopoietic Stem Cell Transplantation Market Overview

29.2. Africa Hematopoietic Stem Cell Transplantation Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.3. Africa Hematopoietic Stem Cell Transplantation Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.4. Africa Hematopoietic Stem Cell Transplantation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Hematopoietic Stem Cell Transplantation Market Competitive Landscape And Company Profiles

30.1. Hematopoietic Stem Cell Transplantation Market Competitive Landscape

30.2. Hematopoietic Stem Cell Transplantation Market Company Profiles

30.2.1. Pluristem Therapeutics Inc. Overview, Products and Services, Strategy and Financial Analysis

30.2.2. Lonza Group AG Overview, Products and Services, Strategy and Financial Analysis

30.2.3. Escape Therapeutics Inc. Overview, Products and Services, Strategy and Financial Analysis

30.2.4. Regen Biopharma Inc. Overview, Products and Services, Strategy and Financial Analysis

30.2.5. Bluebird Bio Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Hematopoietic Stem Cell Transplantation Market Other Major And Innovative Companies

31.1. CellGenix GmbH

31.2. CBR Systems Inc.

31.3. Merck KGaA

31.4. Cord Blood Corporation

31.5. Kiadis Pharma NV

31.6. Marker Therapeutics Inc.

31.7. Taiga Biotechnologies Inc.

31.8. Takeda Pharmaceutical Company Limited

31.9. Talaris Therapeutics Inc.

31.10. ViaCord LLC

31.11. ScienCell Research Laboratories Inc.

31.12. BiolineRx

31.13. Stemcell Technologies Inc.

31.14. ThermoGenesis Holdings Inc.

31.15. MEDIPOST Co. Ltd.

32. Global Hematopoietic Stem Cell Transplantation Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Hematopoietic Stem Cell Transplantation Market

34. Recent Developments In The Hematopoietic Stem Cell Transplantation Market

35. Hematopoietic Stem Cell Transplantation Market High Potential Countries, Segments and Strategies

35.1 Hematopoietic Stem Cell Transplantation Market In 2029 - Countries Offering Most New Opportunities

35.2 Hematopoietic Stem Cell Transplantation Market In 2029 - Segments Offering Most New Opportunities

35.3 Hematopoietic Stem Cell Transplantation Market In 2029 - Growth Strategies

35.3.1 Market Trend Based Strategies

35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations

36.2. Currencies

36.3. Historic And Forecast Inflation Rates

36.4. Research Inquiries

36.5. The Business Research Company

36.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Historic Market Growth, 2019-2024, $ Billion
  • Table 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion
  • Table 3: Global Hematopoietic Stem Cell Transplantation Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 4: Global Hematopoietic Stem Cell Transplantation Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 5: Global Hematopoietic Stem Cell Transplantation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 6: Global Hematopoietic Stem Cell Transplantation Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 7: Global Hematopoietic Stem Cell Transplantation Market, Sub-Segmentation Of Allogeneic, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 8: Global Hematopoietic Stem Cell Transplantation Market, Sub-Segmentation Of Autologous, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 9: Global Hematopoietic Stem Cell Transplantation Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 10: Global Hematopoietic Stem Cell Transplantation Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 11: Asia-Pacific, Hematopoietic Stem Cell Transplantation Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 12: Asia-Pacific, Hematopoietic Stem Cell Transplantation Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 13: Asia-Pacific, Hematopoietic Stem Cell Transplantation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 14: China, Hematopoietic Stem Cell Transplantation Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 15: China, Hematopoietic Stem Cell Transplantation Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 16: China, Hematopoietic Stem Cell Transplantation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 17: India, Hematopoietic Stem Cell Transplantation Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 18: India, Hematopoietic Stem Cell Transplantation Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 19: India, Hematopoietic Stem Cell Transplantation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 20: Japan, Hematopoietic Stem Cell Transplantation Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 21: Japan, Hematopoietic Stem Cell Transplantation Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 22: Japan, Hematopoietic Stem Cell Transplantation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 23: Australia, Hematopoietic Stem Cell Transplantation Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 24: Australia, Hematopoietic Stem Cell Transplantation Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 25: Australia, Hematopoietic Stem Cell Transplantation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 26: Indonesia, Hematopoietic Stem Cell Transplantation Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 27: Indonesia, Hematopoietic Stem Cell Transplantation Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 28: Indonesia, Hematopoietic Stem Cell Transplantation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 29: South Korea, Hematopoietic Stem Cell Transplantation Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 30: South Korea, Hematopoietic Stem Cell Transplantation Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 31: South Korea, Hematopoietic Stem Cell Transplantation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 32: Western Europe, Hematopoietic Stem Cell Transplantation Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 33: Western Europe, Hematopoietic Stem Cell Transplantation Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 34: Western Europe, Hematopoietic Stem Cell Transplantation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 35: UK, Hematopoietic Stem Cell Transplantation Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 36: UK, Hematopoietic Stem Cell Transplantation Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 37: UK, Hematopoietic Stem Cell Transplantation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 38: Germany, Hematopoietic Stem Cell Transplantation Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 39: Germany, Hematopoietic Stem Cell Transplantation Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 40: Germany, Hematopoietic Stem Cell Transplantation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 41: France, Hematopoietic Stem Cell Transplantation Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 42: France, Hematopoietic Stem Cell Transplantation Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 43: France, Hematopoietic Stem Cell Transplantation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 44: Italy, Hematopoietic Stem Cell Transplantation Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 45: Italy, Hematopoietic Stem Cell Transplantation Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 46: Italy, Hematopoietic Stem Cell Transplantation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 47: Spain, Hematopoietic Stem Cell Transplantation Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 48: Spain, Hematopoietic Stem Cell Transplantation Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 49: Spain, Hematopoietic Stem Cell Transplantation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 50: Eastern Europe, Hematopoietic Stem Cell Transplantation Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 51: Eastern Europe, Hematopoietic Stem Cell Transplantation Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 52: Eastern Europe, Hematopoietic Stem Cell Transplantation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 53: Russia, Hematopoietic Stem Cell Transplantation Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 54: Russia, Hematopoietic Stem Cell Transplantation Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 55: Russia, Hematopoietic Stem Cell Transplantation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 56: North America, Hematopoietic Stem Cell Transplantation Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 57: North America, Hematopoietic Stem Cell Transplantation Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 58: North America, Hematopoietic Stem Cell Transplantation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 59: USA, Hematopoietic Stem Cell Transplantation Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 60: USA, Hematopoietic Stem Cell Transplantation Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 61: USA, Hematopoietic Stem Cell Transplantation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 62: Canada, Hematopoietic Stem Cell Transplantation Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 63: Canada, Hematopoietic Stem Cell Transplantation Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 64: Canada, Hematopoietic Stem Cell Transplantation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 65: South America, Hematopoietic Stem Cell Transplantation Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 66: South America, Hematopoietic Stem Cell Transplantation Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 67: South America, Hematopoietic Stem Cell Transplantation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 68: Brazil, Hematopoietic Stem Cell Transplantation Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 69: Brazil, Hematopoietic Stem Cell Transplantation Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 70: Brazil, Hematopoietic Stem Cell Transplantation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 71: Middle East, Hematopoietic Stem Cell Transplantation Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 72: Middle East, Hematopoietic Stem Cell Transplantation Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 73: Middle East, Hematopoietic Stem Cell Transplantation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 74: Africa, Hematopoietic Stem Cell Transplantation Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 75: Africa, Hematopoietic Stem Cell Transplantation Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 76: Africa, Hematopoietic Stem Cell Transplantation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 77: Pluristem Therapeutics Inc. Financial Performance
  • Table 78: Lonza Group AG Financial Performance
  • Table 79: Escape Therapeutics Inc. Financial Performance
  • Table 80: Regen Biopharma Inc. Financial Performance
  • Table 81: Bluebird Bio Inc. Financial Performance

List Of Figures

    Figure 1: Global Historic Market Growth, 2019-2024, $ Billion
  • Figure 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion
  • Figure 3: Global Hematopoietic Stem Cell Transplantation Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 4: Global Hematopoietic Stem Cell Transplantation Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 5: Global Hematopoietic Stem Cell Transplantation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 6: Global Hematopoietic Stem Cell Transplantation Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 7: Global Hematopoietic Stem Cell Transplantation Market, Sub-Segmentation Of Allogeneic, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 8: Global Hematopoietic Stem Cell Transplantation Market, Sub-Segmentation Of Autologous, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 9: Global Hematopoietic Stem Cell Transplantation Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 10: Global Hematopoietic Stem Cell Transplantation Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 11: Asia-Pacific, Hematopoietic Stem Cell Transplantation Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 12: Asia-Pacific, Hematopoietic Stem Cell Transplantation Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 13: Asia-Pacific, Hematopoietic Stem Cell Transplantation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 14: China, Hematopoietic Stem Cell Transplantation Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 15: China, Hematopoietic Stem Cell Transplantation Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 16: China, Hematopoietic Stem Cell Transplantation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 17: India, Hematopoietic Stem Cell Transplantation Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 18: India, Hematopoietic Stem Cell Transplantation Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 19: India, Hematopoietic Stem Cell Transplantation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 20: Japan, Hematopoietic Stem Cell Transplantation Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 21: Japan, Hematopoietic Stem Cell Transplantation Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 22: Japan, Hematopoietic Stem Cell Transplantation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 23: Australia, Hematopoietic Stem Cell Transplantation Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 24: Australia, Hematopoietic Stem Cell Transplantation Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 25: Australia, Hematopoietic Stem Cell Transplantation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 26: Indonesia, Hematopoietic Stem Cell Transplantation Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 27: Indonesia, Hematopoietic Stem Cell Transplantation Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 28: Indonesia, Hematopoietic Stem Cell Transplantation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 29: South Korea, Hematopoietic Stem Cell Transplantation Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 30: South Korea, Hematopoietic Stem Cell Transplantation Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 31: South Korea, Hematopoietic Stem Cell Transplantation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 32: Western Europe, Hematopoietic Stem Cell Transplantation Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 33: Western Europe, Hematopoietic Stem Cell Transplantation Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 34: Western Europe, Hematopoietic Stem Cell Transplantation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 35: UK, Hematopoietic Stem Cell Transplantation Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 36: UK, Hematopoietic Stem Cell Transplantation Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 37: UK, Hematopoietic Stem Cell Transplantation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 38: Germany, Hematopoietic Stem Cell Transplantation Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 39: Germany, Hematopoietic Stem Cell Transplantation Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 40: Germany, Hematopoietic Stem Cell Transplantation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 41: France, Hematopoietic Stem Cell Transplantation Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 42: France, Hematopoietic Stem Cell Transplantation Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 43: France, Hematopoietic Stem Cell Transplantation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 44: Italy, Hematopoietic Stem Cell Transplantation Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 45: Italy, Hematopoietic Stem Cell Transplantation Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 46: Italy, Hematopoietic Stem Cell Transplantation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 47: Spain, Hematopoietic Stem Cell Transplantation Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 48: Spain, Hematopoietic Stem Cell Transplantation Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 49: Spain, Hematopoietic Stem Cell Transplantation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 50: Eastern Europe, Hematopoietic Stem Cell Transplantation Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 51: Eastern Europe, Hematopoietic Stem Cell Transplantation Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 52: Eastern Europe, Hematopoietic Stem Cell Transplantation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 53: Russia, Hematopoietic Stem Cell Transplantation Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 54: Russia, Hematopoietic Stem Cell Transplantation Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 55: Russia, Hematopoietic Stem Cell Transplantation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 56: North America, Hematopoietic Stem Cell Transplantation Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 57: North America, Hematopoietic Stem Cell Transplantation Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 58: North America, Hematopoietic Stem Cell Transplantation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 59: USA, Hematopoietic Stem Cell Transplantation Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 60: USA, Hematopoietic Stem Cell Transplantation Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 61: USA, Hematopoietic Stem Cell Transplantation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 62: Canada, Hematopoietic Stem Cell Transplantation Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 63: Canada, Hematopoietic Stem Cell Transplantation Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 64: Canada, Hematopoietic Stem Cell Transplantation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 65: South America, Hematopoietic Stem Cell Transplantation Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 66: South America, Hematopoietic Stem Cell Transplantation Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 67: South America, Hematopoietic Stem Cell Transplantation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 68: Brazil, Hematopoietic Stem Cell Transplantation Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 69: Brazil, Hematopoietic Stem Cell Transplantation Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 70: Brazil, Hematopoietic Stem Cell Transplantation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 71: Middle East, Hematopoietic Stem Cell Transplantation Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 72: Middle East, Hematopoietic Stem Cell Transplantation Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 73: Middle East, Hematopoietic Stem Cell Transplantation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 74: Africa, Hematopoietic Stem Cell Transplantation Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 75: Africa, Hematopoietic Stem Cell Transplantation Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 76: Africa, Hematopoietic Stem Cell Transplantation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 77: Pluristem Therapeutics Inc. Financial Performance
  • Figure 78: Lonza Group AG Financial Performance
  • Figure 79: Escape Therapeutics Inc. Financial Performance
  • Figure 80: Regen Biopharma Inc. Financial Performance
  • Figure 81: Bluebird Bio Inc. Financial Performance

Frequently Asked Questions

Hematopoietic stem cell transplantation (HSCT) refers to the process of a medical procedure that is used to treat various blood and bone marrow disorders, such as certain genetic disorders and autoimmune diseases. The procedure involves replacing a patient's damaged or diseased bone marrow with healthy stem cells from a donor, which then grow and produce new blood cells in the patient's body. These stem cells can be obtained from bone marrow, peripheral blood, or umbilical cord blood. For further insights on this market, request a sample here

The market major growth driver - Rising Blood Cancer Incidence Fuels Growth In The Hematopoietic Stem Cell Transplantation Market. For further insights on this market, request a sample here

The hematopoietic stem cell transplantation market size has grown strongly in recent years. It will grow from $4.68 billion in 2024 to $5.1 billion in 2025 at a compound annual growth rate (CAGR) of 9.0%. The growth in the historic period can be attributed to early transplantation techniques, limited indications and donor sources, advancements in conditioning regimens, emergence of allogeneic transplants, regulatory milestones. The hematopoietic stem cell transplantation market size is expected to see rapid growth in the next few years. It will grow to " $7.7 billion in 2029 at a compound annual growth rate (CAGR) of 10.8%. The growth in the forecast period can be attributed to expanded treatment indications, donor source diversification, personalized medicine and genomics, regulatory changes and guidelines, market expansion and accessibility. Major trends in the forecast period include advancements in transplant techniques, expansion of indications, emerging cellular therapies, donor diversification, precision medicine approach. For further insights on this market, request a sample here

The hematopoietic stem cell transplantationmarket covered in this report is segmented –
1) By Type: Allogeneic; Autologous
2) By Indication: Leukemia; Lymphatic Disorder; Myeloma; Other Non-Malignant Disorders
3) By Application: Bone Marrow Transplant; Peripheral Blood Stem Cell Transplant; Cord Blood Transplant
4) By End User: Hospital Pharmacy; Retail Pharmacy; Specialty Clinics Subsegments:
1) By Allogeneic: Matched Related Donor Transplantation; Matched Unrelated Donor Transplantation; Cord Blood Transplantation
2) By Autologous: Peripheral Blood Stem Cell Transplantation; Bone Marrow Stem Cell Transplantation For further insights on this market,
request a sample here

North America was the largest region in the hematopoietic stem cell transplantation market in 2024. Asia-Pacific is expected to be the fastest-growing region in the global hematopoietic stem cell transplantation market during the forecast period. The regions covered in the hematopoietic stem cell transplantation market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa For further insights on this market, request a sample here.

Major companies operating in the hematopoietic stem cell transplantation market include Pluristem Therapeutics Inc., Lonza Group AG, Escape Therapeutics Inc., Regen Biopharma Inc., Bluebird Bio Inc., CellGenix GmbH, CBR Systems Inc., Merck KGaA, Cord Blood Corporation, Kiadis Pharma NV, Marker Therapeutics Inc., Taiga Biotechnologies Inc., Takeda Pharmaceutical Company Limited, Talaris Therapeutics Inc., ViaCord LLC, ScienCell Research Laboratories Inc., BiolineRx, Stemcell Technologies Inc., ThermoGenesis Holdings Inc., MEDIPOST Co. Ltd., Anterogen. Co. Ltd., Pharmicell Inc., JCR Pharmaceuticals Co. Ltd., Holostem Terapie Avanzate Srl, Regrow Biosciences Pvt Ltd., Stempeutics Research Pvt Ltd. . For further insights on this market, request a sample here.

Major trends in this market include Product Approvals Drive Advancements In The Hematopoietic Stem Cell Transplantation Market. For further insights on this market, request a sample here.

Customer representative image Book your 30 minutes free consultation with our research experts
Back to top WhatsApp icon